Literature DB >> 8858353

Vitreous laser absorption following fluorescein angiography in diabetic patients.

C Azzolini1, S Fantaguzzi, R Brancato, F Docchio, F Bandello, L Guarisco.   

Abstract

BACKGROUND: Sodium fluorescein staining of the vitreous following fluorescein angiography may interact with laser photocoagulation.
METHODS: We evaluated the laser absorption by fluorescein in the vitreous when photocoagulation is performed following fluorescein angiography in 15 eyes of nine diabetic patients. Axial fluorescein concentration in the vitreous was measured by a scanning vitreal fluorophotometer. The amount of light absorbed by the fluorescein within the vitreous was calculated according to the Lambert-Beer law.
RESULTS: The mean fluorescein concentration ranged from 2.93 ng cm-3 to 105.16 ng cm-3 at 1 h after injection of fluorescein and from 8.03 to 188.56 ng cm-3 after 4 h. Maximum laser absorption at 488 nm ranged from 6.79% (after 1 h) to 14.53% (after 4 h); at 514.5 nm it ranged from 0.96% to 2.14%; at 532 nm it ranged from 0.03% to 0.07%. At lambda > 550 nm, laser absorption was found to be negligible.
CONCLUSIONS: In order to optimize the effect of photocoagulation, especially during long photocoagulation sessions, argon blue laser (488 nm) should be avoided following fluorescein angiography. Argon green laser (514.5 nm) should be used within 1 h after fluorescein injection. Frequency-doubled Nd:YAG laser (532 nm), krypton laser (647 nm) or semiconductor diode laser (810 nm) may be used at any time.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858353     DOI: 10.1007/bf00184856

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Spectrophotometric analysis of sodium fluorescein aqueous solutions. Determination of molar absorption coefficient.

Authors:  M C Mota; P Carvalho; J Ramalho; E Leite
Journal:  Int Ophthalmol       Date:  1991-09       Impact factor: 2.031

2.  Posterior vitreous fluorophotometry in normal subjects.

Authors:  M S Roy; R F Bonner; P M Bungay; M J Podgor; B Collier
Journal:  Arch Ophthalmol       Date:  1986-07

3.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  Early breakdown of the blood-retinal barrier in diabetes.

Authors:  J Cunha-Vaz; J R Faria de Abreu; A J Campos
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

5.  Dimethyl sulfoxide (DMSO) and glycerol, hydroxyl radical scavengers, impair platelet aggregation within and eliminate the accompanying vasodilation of, injured mouse pial arterioles.

Authors:  W I Rosenblum; F El-Sabban
Journal:  Stroke       Date:  1982 Jan-Feb       Impact factor: 7.914

6.  Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.

Authors:  P S Chahal; P J Chowienczyk; E M Kohner
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-07       Impact factor: 4.799

7.  Platelet aggregation induced in the hamster cheek pouch by a photochemical process with excited fluorescein isothiocyanate-dextran.

Authors:  K S Herrmann
Journal:  Microvasc Res       Date:  1983-09       Impact factor: 3.514

8.  Argon laser photocoagulation of fluorescein stained retina--an unrecognised hazard?

Authors:  S Parks; D Aitken; D Keating; G N Dutton
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

9.  Interactions between light and vitreous fluid substitutes.

Authors:  C Azzolini; F Docchio; R Brancato; G Trabucchi
Journal:  Arch Ophthalmol       Date:  1992-10

10.  Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.

Authors:  J G Cunha-Vaz; J R Gray; R C Zeimer; M C Mota; B M Ishimoto; E Leite
Journal:  Diabetes       Date:  1985-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.